MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ABVC — ABVC BioPharma, Inc. Common Stock
NasdaqABVC BioPharma, Inc. Common Stock
$1.02
-0.04(-3.77%)
- O
- 1.07
- H
- 1.08
- L
- 1.02
- V
- 100.14K
⏱️ End-of-day dataAs of Oct 1, 2026
Chart
About ABVC
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateNov 9, 2004
Employees19
Stock ExchangeNasdaq
Ticker SymbolABVC
Websitehttps://www.abvcpharma.com
Key Financial Statistics
| Market Cap | $30.12M |
| P/E Ratio | N/A |
| Dividend Yield | N/A |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.34 - $7,165,605.00 |
| 52-Week Avg Volume | 101.0K |
| VWAP | $1.03 |
| Transactions | 409 |
| Total Recorded Bars | 5,502 days |